Chapters

Transcript

COVID-19 pharmacotherapies and drug-induced sudden cardiac death — Mayo Clinic Cardiovascular Grand Rounds COVID-19 series — Part 4

COVID-19 pharmacotherapies and drug-induced sudden cardiac death — Mayo Clinic Cardiovascular Grand Rounds COVID-19 series — Part 4

Paul A. Friedman, M.D., a Mayo Clinic cardiologist, hosts the Mayo Clinic Cardiovascular Grand Rounds series on COVID-19. Michael J. Ackerman, M.D., Ph.D., who is the Windland Smith Rice Cardiovascular Genomics Research Professor, reviews the mechanisms of drug-induced sudden cardiac death in the setting of COVID-19. Peter A. Noseworthy, M.D., director of the Heart Rhythm and Physiological Monitoring Laboratory at Mayo Clinic, discusses various ECG approaches for QT monitoring, including mobile device technology, in the setting of COVID-19.


Published

April 27, 2020

Created by

Mayo Clinic